Projects per year
Personal profile
Education
- 2017.06 Ph.D., Graduate Institute of Medical Sciences, National Defense Medical Center, Taiwan
- 2007.07 M.S., Graduate Institute of Biopharmaceutical, National Chiayi University, Taiwan
- 2004.06 B.S., Department of Molecular Biology and Biochemistry, National Chiayi University, Taiwan
Experience
- 2025- Associate Professor School of Oral Hygiene, College of Oral Medicine, Taipei Medical University
- 2020-2025 Assistant Professor School of Oral Hygiene, College of Oral Medicine, Taipei Medical University
- 2017.7-2020.1 Postdoctoral Fellow Genomic Research Center, Academia Sinica
Awards
- 2018.1-2019.12 Awarded Academia Sinica Postdoctoral Fellowship
- 2017 NHRI Research Day, Out-standing Oral Presentation Award (1st award)
- 2016 GRC Outstanding Performance Award. Genomic Research Center, Academia Sinica
Research Interests
- Oral cancer biomarker
- microRNA
Fingerprint
Dive into the research topics where Wei-Min Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Mechanism Study of Novel Tumor Suppressor Pmm1 Regulates Warburg Effect and Endoplasmic Reticulum Stress in Oral Cancer( III )
Chang, W.-M. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
The Mechanism Study of Novel Tumor Suppressor Pmm1 Regulates Warburg Effect and Endoplasmic Reticulum Stress in Oral Cancer( II )
Chang, W.-M. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
The Mechanism Study of Novel Tumor Suppressor Pmm1 Regulates Warburg Effect and Endoplasmic Reticulum Stress in Oral Cancer( I )
Chang, W.-M. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Develop the Lingo2-Targeting Small Rna Nanoparticles for Precise Therapy for Recurrent Head and Neck Cancer
Chang, W.-M. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
新聘教師研究補助
Chang, W.-M. (PI)
6/1/20 → 11/30/21
Project: B - Project of TMU › g - Research Grants for Newly Hired Faculty
-
EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/STAT3 axis
Peng, H. Y., Chang, K. Y., Chang, W. M., Wu, C. Y., Lee, H. L., Chang, Y. C., Liu, K. J., Shiah, S. G., Kuo, C. C. & Chang, J. Y., Aug 2025, In: Neoplasia (United States). 66, 101193.Research output: Contribution to journal › Article › peer-review
Open Access -
Ex-vivo investigation of human salivary microbial growth with lysogeny broth for translational research–A pilot study
Yang, Y. H., Yu, J. J., Han, H. Y., Chang, W. M. & Wang, C. W., Jan 2025, In: Journal of Dental Sciences. 20, 1, p. 437-443 7 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 Expression
Peng, H. Y., Chang, C. W., Wu, P. H., Li, L. J., Lin, Y. L., Hsiao, M., Chang, J. Y., Chang, P. M. H., Lee, H. L. & Chang, W. M., Feb 2025, In: International journal of molecular sciences. 26, 3, 1077.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Synergistic Effect of Strontium Doping and Surfactant Addition in Mesoporous Bioactive Glass for Enhanced Osteogenic Bioactivity and Advanced Bone Regeneration
Chen, Y. Y., Ma, T. L., Chang, P. J., Chiou, Y. J., Chang, W. M., Weng, C. F., Chen, C. Y., Chang, Y. K. & Lin, C. K., Jan 2025, In: Polymers. 17, 2, 187.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
The miR-876-5p/SOCS4/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responses
Peng, H. Y., Huang, Y. L., Wu, P. H., Li, L. J., Peng, B. Y., Wu, C. Y., Lin, Y. L., Hsiao, M., Chang, J. Y., Mu-Hsin Chang, P., Lee, H. L. & Chang, W. M., Dec 2025, In: Cancer Cell International. 25, 1, 114.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Datasets
-
Additional file 2 of Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma
Chen, M.-H. (Creator), Chang, W.-M. (Creator), Jung, S.-M. (Contributor), Yeh, C.-N. (Creator), Tung, M.-C. (Contributor), Chien, M.-H. (Creator), Jan, Y.-H. (Creator), Yang, Y.-C. (Contributor), Hsiao, M. (Creator) & Lai, T.-C. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.14471535.v1, https://doi.org/10.6084%2Fm9.figshare.14471535.v1
Dataset
-
Additional file 1 of Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma
Tung, M.-C. (Contributor), Lai, T.-C. (Contributor), Chien, M.-H. (Creator), Chen, M.-H. (Creator), Yang, Y.-C. (Contributor), Yeh, C.-N. (Creator), Jan, Y.-H. (Creator), Chang, W.-M. (Creator), Jung, S.-M. (Contributor) & Hsiao, M. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.14471532.v1, https://doi.org/10.6084%2Fm9.figshare.14471532.v1
Dataset
-
Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma
Chien, M.-H. (Creator), Hsiao, M. (Creator), Jan, Y.-H. (Creator), Yang, Y.-C. (Contributor), Chang, W.-M. (Creator), Yeh, C.-N. (Creator), Jung, S.-M. (Contributor), Chen, M.-H. (Creator), Tung, M.-C. (Contributor) & Lai, T.-C. (Contributor), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5399457.v1, https://doi.org/10.6084%2Fm9.figshare.c.5399457.v1
Dataset